Brain Research Foundation Statement On DEA's Response To Industrial Hemp Petitions
CHICAGO, Aug. 11, 2016 /PRNewswire/ -- Independent, peer-reviewed research funded by Brain Research Foundation (BRF) indicates that the developing brain – this means young adults – is at risk from the active ingredient in cannabis known as THC. When young adults under the age of 17 habitually use cannabis their decision-making and cognitive ability may be compromised for life. In addition, the incidence of serious mental illness such as schizophrenia was found to increase among those who used cannabis in their early years. Finally, Brain Research Foundation points to the concerns of our researchers that new, more powerful synthetic THC may greatly increase the identified risks.
The role of BRF is to help answer questions about the brain and central nervous system through scientific research. With regards to medical marijuana, more research is required to fully understand its medical potential and side effects. Peer-reviewed research funded by BRF raises great concern about the effects on the developing brain. Every state that has legalized cannabis or contemplated doing so should familiarize itself with the latest research and factor the research results into their regulatory decision-making.
Contact:Jim Prendergast 312-280-8706 email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brain-research-foundation-statement-on-deas-response-to-industrial-hemp-petitions-300312595.html
SOURCE Brain Research Foundation